Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and Sarcoidosis

ABSTRACT

Lung transplantation for respiratory failure due to lymphangioleiomyomatosis, histiocytosis X, and sarcoidosis is a therapeutic option in selected patients. These indications account for less than 6% of all lung transplant procedures, and experience is relatively scarce. Pulmonary function testing at evaluation usually shows an obstructive pattern in lymphangioleiomyomatosis, whereas histiocytosis presents with a mixed pattern, and sarcoidosis with a restrictive pattern. Lung diffusion capacity is similarly reduced, however, only histiocytosis and sarcoidosis are often associated with pulmonary hypertension. In all three diseases extrapulmonary manifestations, although of different kinds, are common and must be investigated before transplantation to avoid posttransplant diagnostic pitfalls. In all these diseases, single and bilateral transplantation show comparable results. Typical complications in lymphangioleiomyomatosis include intraoperative severe intrathoracic bleeding, posttransplant chylothorax, pneumothorax, and bleeding of angiomyolipomas. In histiocytosis, extrapulmonary manifestations in bones and pituitary gland may progress. These diseases typically recur in the allograft, leading to clinical symptoms in histiocytosis whereas recurrence in lymphangioleiomyomatosis and sarcoidosis is most often asymptomatic. Survival is similar to patients transplanted for other diseases.

KEYWORD

Lung transplantation - lymphangioleiomyomatosis - eosinophilic granuloma - histiocytosis X - sarcoidosis

REFERENCES

• 1 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000.  J Heart Lung Transplant . 2000;  19 909-931
• 2 Maurer J R, Frost A E, Estenne M, Higenbottam T, Glanville A R. International guidelines for the selection of lung transplant candidates: The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.  Transplantation . 1998;  66 951-956
• 3 Yeatman M, McNeil K, Smith J A. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital.  J Heart Lung Transplant . 1996;  15 144-149
• 4 Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.  Thorax . 1999;  54 254-264
• 5 Rappaport D C, Weisbrod G L, Herman S J, Chamberlain D W. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases.  Am J Roentgenol . 1989;  152 961-964
• 6 Costello L C, Hartman T E, Ryu J H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex.  Mayo Clin Proc . 2000;  75 591-594
• 7 Ryu J H. Tuberous sclerosis complex and LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 407-418
• 8 Smolarek T A, Wessner L L, McCormack F X, Mylet J C, Menon A G, Henske E P. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.  Am J Hum Genet . 1998;  62 810-815
• 9 Sullivan E J, Beck G J, Stoller J K. The registry for individuals with lymphangioleiomyomatosis. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation New York, NY: Marcel Dekker Inc 1999: 99-110
• 10 NHLBI. Workshop summary: report of workshop on lymphangioleiomyomatosis.  Am J Respir Crit Care Med . 1999;  159 679-683
• 11 Boehler A, Speich R, Russi E W, Weder W. Lung transplantation for lymphangioleiomyomatosis.  N Engl J Med . 1996;  335 1275-1280
• 12 Boehler A, Speich R, Russi E W, Weder W. International survey on lung transplantation in lymphangioleiomyomatosis. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 79-98
• 13 Trulock E P. Lung transplantation: special considerations and outcome in LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 65-78
• 14 Silverstein E, Ellis K, Wolff M, Jaretzki A. Pulmonary lymphangioleiomyomatosis.  Am J Roentgenol . 1974;  120 12-50
• 15 Urban T, Lazor R, Lacronique J. Pulmonary lymphangioleiomyomatosis.  Medicine . 1999;  78 321-337
• 16 Crausman R, Lynch D, Mortenson R. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.  Chest . 1996;  109 131-137
• 17 Pigula F A, Griffith B P, Zenati M A, Dauber J H, Yousem S A, Keenan R J. Lung transplantation for respiratory failure resulting from systemic disease.  Ann Thorac Surg . 1997;  64 1630-1634
• 18 Avila N A, Kelly J A, Chu S C, Dwyer A J, Moss J. Lymphangioleiomyomatosis: abdominopelvic CT and US findings.  Radiology . 2000;  216 147-153
• 19 Maziak D E, Kesten S, Rappaport D C, Maurer J. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.  Eur Respir J . 1996;  9 402-405
• 20 Oesterling J E, Fishman E K, Goldman S M, Marshall F F. The management of renal angiomyolipoma.  J Urol . 1986;  135 1121-1124
• 21 Blute M L, Malek R S, Segura J W. Angiomyolipoma: clinical metamorphosis and concepts for management.  J Urol . 1988;  139 20-24
• 22 Kennelly M J, Grossman H B, Cho K J. Outcome and analysis of 42 cases of renal angiomyolipoma.  J Urol . 1994;  152 1988-1991
• 23 Matsui K, Takeda K, Yu Z-X. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study.  Am J Respir Crit Care Med . 2000;  161 1002-1009
• 24 Logginidou H, Ao X, Russo I, Henske E P. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.  Chest . 2000;  117 25-30
• 25 Nine J S, Yousem S A, Paradis I L, Keenan R, Griffith B P. Lymphangioleiomyomatosis: recurrence after lung transplantation.  J Heart Lung Transplant . 1994;  13 714-719
• 26 O'Brien J D, Lium J H, Parosa J F, Deyoung B R, Wick M R, Trulock E P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.  Am J Respir Crit Care Med . 1995;  151 2033-2036
• 27 Bittmann I, Dose T B, Müller C, Dienemann H, Vogelmeier C, Löhrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation.  Hum Pathol . 1997;  26 1420-1423
• 28 Tazi A, Soler P, Hance A J. Adult pulmonary Langerhans' cell histiocytosis.  Thorax . 2000;  55 405-416
• 29 Vassallo R, Ryu J H, Colby T V, Hartman T, Limper A H. Pulmonary langerhans'-cell histiocytosis.  N Engl J Med . 2000;  342 1969-1978
• 30 Delobbe A, Durieu J, Duhamel A, Wallaert B, and the groupe d'etude en pathologie interstitielle de la societe de pathologie thoracique du nord. Determinants of survival in pulmonary Langerhans'cell granulomatosis (histiocytosis X).  Eur Respir J . 1996;  9 2002-2006
• 31 Schönfeld N, Frank W, Wenig S. Clinical and radiological features, lung function and therapeutic results in pulmonary histiocytosis X.  Respiration . 1993;  60 38-44
• 32 Fartoukh M, Humbert M, Capron F. Severe pulmonary hypertension in histiocytosis X.  Am J Respir Crit Care Med . 2000;  161 216-223
• 33 Kaltsas G A, Powles T B, Evanson J. Hypothalamo-pituitary abnormalities in adult patients with Langerhans' cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.  J Clin Endocrinol Metab . 2000;  85 1370-1376
• 34 Gabbay E, Dark J H, Ashcroft T. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax . 1998;  53 326-327
• 35 Egan T M, Detterbeck F C, Keagy B A, Turpin S, Mill M R, Wilcox B R. Single lung transplantation for eosinophilic granulomatosis.  Southern Med J . 1992;  85 551-553
• 36 Etienne B, Bertocchi M, Gamondes J-P. Relapsing pulmonary Langerhans' cell histiocytosis after lung transplantation.  Am J Respir Crit Care Med . 1998;  157 288-291
• 37 Habib S B, Congleton J, Carr D. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation.  Thorax . 1998;  53 323-325
• 38 Egeler M R, Favara B E, van Meurs M, Laman J D, Claassen E. Differential in situ cytokine profiles of Langerhans'-like cells and T cells in Langerhans' cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.  Blood . 1999;  94 4195-4201
• 39 Newman L S, Rose C S, Maier L A. Sarcoidosis.  N Engl J Med . 1997;  336 1224-1234
• 40 Judson M A. An approach to the treatment of pulmonary sarcoidosis with corticosteroids.  Chest . 1999;  115 1158-1165
• 41 Takada K, Ina Y, Noda M, Sato T, Yamamoto M, Morishita M. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis.  J Clin Epidemiol . 1993;  46 359-366
• 42 Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases.  Respiration . 1994;  61 219-225
• 43 Du Bois M R. Corticosteroids in sarcoidosis: friend or foe?.  Eur Respir J . 1994;  7 1203-1209
• 44 Lower E E, Baughman R P. The use of low dose methotrexate in refractory sarcoidosis.  Am J Med Sci . 1990;  299 153-157
• 45 Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.  Arch Pathol Lab Med . 1995;  119 167-172
• 46 Baughman R P, Winget D B, Bowen E H, Lower E E. Predicting respiratory failure in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis . 1997;  14 154-158
• 47 Arcasoy S M, Edelman J D, Wahl P M, Blumenthal N, Palevsky H I, Kotloff R M. Characteristics and outcome of patients with sarcoidosis listed for lung transplantation.  Am J Respir Crit Care Med . 2000;  161 A720
• 48 Judson M A. Lung transplantation for pulmonary sarcoidosis.  Eur Respir J . 1998;  11 738-744
• 49 Viskum K, Vestbo J. The prognosis of extrapulmonary sarcoidosis.  Sarcoidosis . 1994;  11 73-75
• 50 Walker S, Mikhail G, Banner N. Medium term results of lung transplantation for end stage pulmonary sarcoidosis.  Thorax . 1998;  53 281-284
• 51 Martinez F J, Orens J B, Deeb M, Brunsting L A, Flint A, Lynch III P J. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation.  Chest . 1994;  106 1597-1599
• 52 Martel S, Carre P C, Carrera G, Pipy B, Leophonte P J, and the Toulouse Lung Transplantation Group. Tumour necrosis factor-alpha gene expression by alveolar macrophages in human lung allograft recipient with recurrence of sarcoidosis.  Eur Respir J . 1996;  9 1087-1089
• 53 Johnson B A, Duncan S R, Ohori N P. Recurrence of sarcoidosis in pulmonary allograft recipients.  Am Rev Respir Dis . 1993;  148 1373-1377
• 54 Kazerooni E A, Cascade P N. Sarcoidosis: recurrence of primary disease in transplanted lungs.  Radiology . 1994;  192 461-464
• 55 Muller C, Briegel J, Haller M, and the Munich Lung Transplant Group. Sarcoidosis recurrence following lung transplantation.  Transplantation . 1996;  61 1117-1119
• 56 Björtuft O, Foerster A, Boe J, Geiran O. Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient.  J Heart Lung Transplant . 1994;  13 24-29
• 57 Klemen H, Husain A N, Cagle P T, Garrity E R, Popper H H. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung: a PCR-based study on four cases.  Virchows Arch . 2000;  436 365-369
• 58 Nunley D R, Hattler B, Keenan R J. Lung transplantation for end-stage pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 93-100